Clinical short communication
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

https://doi.org/10.1016/j.jns.2020.116803Get rights and content

Cited by (0)

1

These recommendations have been prepared and endorsed by an international working group of MG experts in response to the COVID-19 pandemic on 23 March 2020. The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) endorsed these recommendations on 25 March 2020.

2

These authors contributed equally.

View Abstract